Avendus, SBI Life pick up over 2.5% secondaries in Aragen for Rs 300 crore
Avendus Future Leaders Fund III and SBI Life Insurance have jointly invested Rs 300 crore in Aragen Life Sciences, a Hyderabad-based CRDMO. The investment involves acquiring a stake from the GVK Group’s Reddy family. This move allows investors to capitalize on the increasing trend of global pharmaceutical companies outsourcing R&D and manufacturing to India.🕒 1 min read
Avendus Future Leaders Fund III and SBI Life Insurance have jointly invested Rs 300 crore in Aragen Life Sciences, a Hyderabad-based CRDMO. The investment involves acquiring a stake from the GVK Group’s Reddy family. This move allows investors to capitalize on the increasing trend of global pharmaceutical companies outsourcing R&D and manufacturing to India.
Continue Reading
- India Reports GDP Growth Of 7.8% In Q4 On Services Sector Output Boost
- No Long Clothes In Lock-Ups: Mumbai Police Tighten Anti-Suicide Measures
-
IND vs ENG: ‘I’ll be disappointed…’ – Ravi Shastri on Shubman Gill
- Soaked Almonds Or Anjeer: Which is A Better Choice For Digestion, Skin And Weight Loss
- Gujarat Couple, 3 Children Found Dead, Relatives Suspect Debt Suicide Pact
- India Brings Global South To The Table As New Delhi Hosts AI Impact Summit
- Warner Bros-Netflix deal: Company rejects Paramount takeover bid; backs $72-bn Netflix deal for studio and streaming business
- Delhi Weather: IMD Issues Orange Alert, National Capital Records Wettest May
- Lower oil prices to offer relief to consumers, government
- GST reforms: SBI sees Rs 1.98 lakh crore consumption boost; warns of Rs 85k crore annual revenue hit